Cipla 125 Pill - pink capsule/oblong, 16mm
Pill with imprint Cipla 125 is Pink, Capsule/Oblong and has been identified as Topiramate 200 mg. It is supplied by Cipla USA Inc.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Cipla 125
Topiramate
- Imprint
- Cipla 125
- Strength
- 200 mg
- Color
- Pink
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0125
- Inactive Ingredients
-
lactose monohydrate,
hypromellose 2910 (6 mPa.s),
hypromellose 2910 (3 mPa.s),
magnesium stearate,
polyethylene glycol 400,
polysorbate 80,
corn starch,
sodium starch glycolate type A potato,
titanium dioxide,
microcrystalline cellulose,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "Cipla 125"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,332)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Topiramate drug information
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Qudexy XR, Eprontia, Topiragen
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Qudexy XR, Eprontia
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.